Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.17 trillion and total revenue of $110.17 billion.
Market Cap
1.17T
Revenue
110.17B
Profits
-39.72B
PE Ratio
n/a
Profit Margin
-36.05%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.01B | 0.96% | 1,445,357 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.53B | 1.21% | 637,726 | 14.34B |
| 3 | ARGX | argenx SE | 51.73B | 2.36% | 228,269 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 45.01B | 1.92% | 1,228,638 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.38B | 1.43% | 316,748 | 5.34B |
| 6 | INSM | Insmed Incorporated | 33.11B | 1.50% | 1,309,472 | 606.42M |
| 7 | RVMD | Revolution Medicines, Inc. | 29.13B | 7.86% | 8,202,162 | - |
| 8 | RPRX | Royalty Pharma plc | 28.16B | 0.81% | 3,887,146 | 2.38B |
| 9 | BNTX | BioNTech SE | 24.89B | 1.77% | 1,114,434 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 20.96B | 4.26% | 5,355,308 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.84B | 0.59% | 3,954,340 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.44B | 2.24% | 1,519,827 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.86B | 3.05% | 1,938,445 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 16.17B | 4.09% | 2,322,728 | - |
| 15 | ASND | Ascendis Pharma A/S | 15.44B | 0.52% | 515,158 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.11B | 0.08% | 2,246,832 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.68B | 2.41% | 1,595,178 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.38B | 2.94% | 1,071,077 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.13% | 302,687 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.91B | 2.00% | 2,533,407 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 1.08% | 1,596,840 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.88B | 3.70% | 1,050,526 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | 8.39% | 703,317 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.42B | 3.28% | 820,744 | 638.50M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.34B | 4.55% | 1,467,260 | 1.09B |
| 26 | TECH | Bio-Techne Corporation | 9.18B | 1.96% | 2,543,579 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 9.03B | 1.64% | 1,005,812 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.26B | 1.30% | 434,837 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.17B | -0.55% | 1,897,124 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.97B | 0.49% | 1,459,941 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.95B | 0.97% | 389,160 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.85B | 4.11% | 15,645,827 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.34B | 1.51% | 573,053 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.74B | -1.03% | 115,947 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.02% | 543,076 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.68B | 7.33% | 849,447 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.53B | 1.99% | 559,686 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.06% | 6,226,107 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.12% | 3,860,332 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 6.04B | 3.68% | 1,400,652 | 1.73B |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.96B | 0.54% | 520,405 | 189.76M |
| 42 | COGT | Cogent Biosciences, Inc. | 5.88B | -0.08% | 2,338,923 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.85B | 0.42% | 894,516 | 521.31M |
| 44 | CELC | Celcuity Inc. | 5.84B | 0.37% | 673,606 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 5.71B | 5.54% | 2,006,888 | 812.03M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.69B | 0.06% | 1,754,295 | - |
| 47 | CGON | CG Oncology, Inc. | 5.68B | -0.62% | 2,010,063 | 4.04M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | 1.28% | 851,666 | 7.50M |
| 49 | ERAS | Erasca, Inc. | 5.55B | 9.44% | 5,467,098 | - |
| 50 | CRSP | CRISPR Therapeutics AG | 5.46B | 3.70% | 2,100,126 | 3.51M |
| 51 | IMVT | Immunovant, Inc. | 5.40B | 5.69% | 2,314,415 | - |
| 52 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.02% | 4,524,967 | 1.00B |
| 53 | TGTX | TG Therapeutics, Inc. | 5.10B | 2.28% | 1,412,787 | 616.29M |
| 54 | SYRE | Spyre Therapeutics, Inc. | 5.03B | 1.17% | 1,672,982 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.02B | 5.46% | 1,140,607 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.65B | 0.88% | 811,160 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.63B | 8.85% | 570,598 | 268.09M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 4,451,877 | 634.21M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 2.82% | 710,262 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.12B | 1.46% | 2,150,279 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.96B | -4.99% | 1,620,327 | 22.50M |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.89B | 37.23% | 14,944,942 | 490.73M |
| 63 | GPCR | Structure Therapeutics Inc. | 3.77B | -1.90% | 1,050,169 | - |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | 2.61% | 1,972,975 | 1.07B |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.74B | -4.80% | 547,263 | 803.79M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.01% | 1,069,758 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.46B | 5.65% | 2,744,699 | 1.03B |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.43B | 11.60% | 3,538,911 | 62.38M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.32B | 9.25% | 1,617,512 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.27B | 4.26% | 2,279,825 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.20B | 3.35% | 2,196,186 | 588.99M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.20B | 3.81% | 807,082 | - |
| 73 | VERA | Vera Therapeutics, Inc. | 3.17B | 1.49% | 1,249,673 | - |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | 1.60% | 278,356 | 451.36M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | 4.02% | 1,611,490 | 376.07M |
| 76 | BEAM | Beam Therapeutics Inc. | 3.01B | 0.40% | 2,191,308 | 139.74M |
| 77 | ALMS | Alumis Inc. | 2.91B | 1.64% | 1,211,884 | 24.05M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.88B | 2.77% | 660,418 | 247.00M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.84B | -1.43% | 3,809,355 | 218.71M |
| 80 | MANE | Veradermics, Incorporated | 2.80B | 5.09% | 476,705 | - |
| 81 | KOD | Kodiak Sciences Inc. | 2.78B | 7.44% | 1,344,928 | - |
| 82 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.04% | 4,265,834 | 190.41M |
| 83 | IRON | Disc Medicine, Inc. | 2.69B | 3.01% | 352,773 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.68B | 2.33% | 771,169 | - |
| 85 | RLAY | Relay Therapeutics, Inc. | 2.64B | -3.34% | 4,089,894 | 15.36M |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.62B | 2.27% | 844,239 | 1.55M |
| 87 | IMNM | Immunome, Inc. | 2.59B | 1.24% | 1,290,934 | 6.94M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.50B | 1.06% | 5,821,046 | 510.17M |
| 89 | ZLAB | Zai Lab Limited | 2.47B | 2.91% | 614,801 | 460.16M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | 3.98% | 1,819,916 | 673.00M |
| 91 | AAPG | Ascentage Pharma Group International | 2.33B | 0.94% | 861 | 82.08M |
| 92 | NKTR | Nektar Therapeutics | 2.33B | 1.01% | 523,733 | 55.23M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.65% | 2,294,685 | 2.20B |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | 0.59% | 640,090 | - |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | 2.83% | 1,359,759 | 276.98M |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.14% | 1,275,310 | 158.18M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.19B | -1.44% | 1,618,054 | - |
| 98 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | 0.74% | 888,035 | 172.35M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 0.06% | 1,302,014 | 283.06M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.12B | 2.31% | 663,369 | 184.42M |
| 101 | ANAB | AnaptysBio, Inc. | 2.02B | 2.17% | 486,423 | 234.60M |
| 102 | CAPR | Capricor Therapeutics, Inc. | 2.00B | 0.52% | 950,146 | 11.13M |
| 103 | ZYME | Zymeworks Inc. | 1.99B | 3.10% | 743,568 | 105.97M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.45% | 652,549 | 54.03M |
| 105 | SION | Sionna Therapeutics, Inc. | 1.95B | 3.66% | 900,097 | - |
| 106 | GLPG | Galapagos NV | 1.92B | 1.03% | 176,714 | 1.31B |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -1.13% | 2,606,170 | 51.95M |
| 108 | TYRA | Tyra Biosciences, Inc. | 1.90B | -0.98% | 1,415,986 | - |
| 109 | PHVS | Pharvaris N.V. | 1.88B | 2.87% | 134,766 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 3.51% | 9,065,612 | 74.68M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 0.41% | 121,620 | - |
| 112 | MESO | Mesoblast Limited | 1.85B | -0.61% | 238,914 | 65.38M |
| 113 | TRVI | Trevi Therapeutics, Inc. | 1.80B | 5.33% | 1,434,634 | - |
| 114 | INVA | Innoviva, Inc. | 1.79B | 0.92% | 582,829 | 411.33M |
| 115 | VCEL | Vericel Corporation | 1.79B | 2.03% | 488,930 | 276.26M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.75B | 3.65% | 2,986,323 | 67.67M |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.73B | 4.33% | 496,199 | - |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | 0.83% | 693,095 | 868.45M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 2.45% | 1,279,200 | 71.78M |
| 120 | NUVB | Nuvation Bio Inc. | 1.66B | 3.19% | 2,341,492 | 62.90M |
| 121 | GENB | Generate Biomedicines, Inc. | 1.64B | 0.70% | 366,092 | 31.89M |
| 122 | OCS | Oculis Holding AG | 1.63B | 1.62% | 157,864 | 1.51M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.61B | 1.14% | 325,496 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.61B | 0.70% | 369,712 | 400.02M |
| 125 | VIR | Vir Biotechnology, Inc. | 1.61B | 7.95% | 2,698,234 | 68.56M |
| 126 | NBTX | Nanobiotix S.A. | 1.59B | -0.53% | 101,341 | 38.27M |
| 127 | BHVN | Biohaven Ltd. | 1.57B | 3.16% | 1,592,400 | - |
| 128 | MBX | MBX Biosciences, Inc. | 1.56B | - | 462,094 | - |
| 129 | VRDN | Viridian Therapeutics, Inc. | 1.55B | 2.64% | 1,719,837 | 70.85M |
| 130 | ARDX | Ardelyx, Inc. | 1.55B | - | 3,737,813 | 407.32M |
| 131 | SVRA | Savara Inc. | 1.54B | 2.53% | 1,265,092 | - |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.50B | 3.79% | 823,622 | - |
| 133 | IOVA | Iovance Biotherapeutics, Inc. | 1.50B | 5.20% | 13,922,189 | 263.50M |
| 134 | IMTX | Immatics N.V. | 1.47B | 0.69% | 247,507 | 56.67M |
| 135 | OLMA | Olema Pharmaceuticals, Inc. | 1.42B | 2.32% | 794,966 | - |
| 136 | PGEN | Precigen, Inc. | 1.41B | -4.56% | 4,185,551 | 9.68M |
| 137 | ATAI | AtaiBeckley Inc. | 1.40B | 1.58% | 3,544,333 | 4.09M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -0.28% | 754,858 | 123.67M |
| 139 | WVE | Wave Life Sciences Ltd. | 1.39B | 1.79% | 6,266,635 | 42.73M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.38B | 0.95% | 2,453,668 | 2.50M |
| 141 | NVAX | Novavax, Inc. | 1.37B | 3.45% | 3,298,186 | 1.12B |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | 6.56% | 2,036,989 | 9.77M |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.35B | 1.90% | 1,075,884 | - |
| 144 | DBVT | DBV Technologies S.A. | 1.35B | -2.26% | 311,448 | 5.64M |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 0.53% | 1,213,210 | - |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 1.43% | 695,393 | 10.00M |
| 147 | PHAR | Pharming Group N.V. | 1.27B | 4.25% | 22,189 | 376.13M |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.22B | 3.17% | 335,111 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 7.40% | 200,362 | 1.30M |
| 150 | EYPT | EyePoint, Inc. | 1.20B | -1.24% | 598,467 | 31.37M |
| 151 | MPLT | MapLight Therapeutics, Inc. | 1.19B | 2.70% | 163,933 | - |
| 152 | ABCL | AbCellera Biologics Inc. | 1.14B | 2.73% | 3,196,870 | 75.13M |
| 153 | GERN | Geron Corporation | 1.13B | 2.31% | 17,827,990 | 183.88M |
| 154 | SEPN | Septerna, Inc. | 1.08B | 3.38% | 213,430 | 45.95M |
| 155 | QURE | uniQure N.V. | 1.07B | -4.63% | 1,218,982 | 16.10M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.06B | 1.25% | 1,013,656 | - |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 1.68% | 1,138,695 | 291.85M |
| 158 | GHRS | GH Research PLC | 1.04B | 2.82% | 83,234 | - |
| 159 | KALV | KalVista Pharmaceuticals, Inc. | 1.04B | 3.57% | 1,458,854 | 73.62M |
| 160 | URGN | UroGen Pharma Ltd. | 1.03B | 4.64% | 617,477 | 109.79M |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | - | 1,043,390 | 175.11M |
| 162 | AKTS | Aktis Oncology, Inc. | 986.12M | 2.88% | 213,276 | 6.50M |
| 163 | IVA | Inventiva S.A. | 982.77M | 9.98% | 1,769,470 | 9.31M |
| 164 | CTMX | CytomX Therapeutics, Inc. | 981.44M | 3.42% | 7,158,406 | 76.20M |
| 165 | CMPX | Compass Therapeutics, Inc. | 979.68M | 4.62% | 3,542,882 | 850.00K |
| 166 | EVMN | Evommune, Inc. | 959.17M | -1.41% | 303,082 | 13.00M |
| 167 | JBIO | Jade Biosciences, Inc. | 958.71M | 5.14% | 782,252 | - |
| 168 | ANNX | Annexon, Inc. | 930.75M | -0.17% | 2,146,582 | - |
| 169 | SANA | Sana Biotechnology, Inc. | 928.70M | 8.41% | 16,411,205 | - |
| 170 | JANX | Janux Therapeutics, Inc. | 927.07M | 2.28% | 758,368 | 10.00M |
| 171 | MGTX | MeiraGTx Holdings plc | 919.53M | 17.24% | 1,209,594 | 81.39M |
| 172 | XNCR | Xencor, Inc. | 917.47M | 3.65% | 806,924 | 125.58M |
| 173 | FTRE | Fortrea Holdings Inc. | 896.67M | 2.24% | 600,262 | 2.72B |
| 174 | DRUG | Bright Minds Biosciences Inc. | 874.86M | 4.65% | 99,064 | - |
| 175 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | 2.10% | 3,390,886 | - |
| 176 | CGEM | Cullinan Therapeutics, Inc. | 868.55M | 0.70% | 889,598 | - |
| 177 | VOR | Vor Biopharma Inc. | 859.93M | -0.63% | 1,165,759 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 854.78M | 0.61% | 489,233 | 107.46M |
| 179 | OMER | Omeros Corporation | 852.43M | 4.04% | 777,267 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 850.33M | -0.46% | 1,360,365 | 14.08M |
| 181 | MNKD | MannKind Corporation | 846.10M | 3.79% | 3,566,587 | 348.97M |
| 182 | MRVI | Maravai LifeSciences Holdings, Inc. | 843.18M | 7.19% | 3,587,480 | 185.74M |
| 183 | ANRO | Alto Neuroscience, Inc. | 824.83M | 0.27% | 534,282 | - |
| 184 | SGP | SpyGlass Pharma, Inc. | 819.62M | 2.72% | 90,279 | - |
| 185 | SLDB | Solid Biosciences Inc. | 809.76M | -1.91% | 1,586,975 | - |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 808.28M | 1.75% | 836,251 | 84.28M |
| 187 | KURA | Kura Oncology, Inc. | 807.33M | 4.82% | 1,703,671 | 67.48M |
| 188 | FBRX | Forte Biosciences, Inc. | 793.58M | 5.95% | 292,283 | - |
| 189 | DSGN | Design Therapeutics, Inc. | 779.54M | 2.27% | 311,396 | - |
| 190 | RLMD | Relmada Therapeutics, Inc. | 754.15M | -2.57% | 1,427,594 | - |
| 191 | TENX | Tenax Therapeutics, Inc. | 743.44M | 1.93% | 634,058 | - |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 741.44M | 2.34% | 1,255,761 | 49.80M |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 734.70M | 2.57% | 584,298 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 715.90M | 1.95% | 36,473 | 116.59M |
| 195 | ARVN | Arvinas, Inc. | 703.57M | 3.97% | 841,321 | 262.60M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 689.12M | 2.49% | 454,196 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 672.20M | 4.48% | 302,314 | - |
| 198 | PRME | Prime Medicine, Inc. | 655.19M | 1.09% | 2,443,337 | 4.63M |
| 199 | CBIO | Crescent Biopharma, Inc. | 648.34M | 8.50% | 592,109 | 10.84M |
| 200 | OCGN | Ocugen, Inc. | 608.22M | 0.56% | 4,591,079 | 4.41M |
| 201 | MDXG | MiMedx Group, Inc. | 582.38M | - | 1,194,950 | 418.63M |
| 202 | RIGL | Rigel Pharmaceuticals, Inc. | 579.87M | 4.74% | 414,112 | 294.28M |
| 203 | ANL | Adlai Nortye Ltd. | 578.60M | 30.02% | 1,085,928 | 5.40M |
| 204 | CRMD | CorMedix Inc. | 577.07M | -0.27% | 1,164,629 | 311.71M |
| 205 | PROK | ProKidney Corp. | 576.66M | -2.05% | 1,619,637 | 893.00K |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 574.79M | 0.72% | 598,134 | 106.47M |
| 207 | EIKN | Eikon Therapeutics, Inc. | 574.41M | 7.50% | 440,818 | - |
| 208 | PRTA | Prothena Corporation plc | 571.17M | 2.91% | 370,923 | 9.68M |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 565.86M | -1.37% | 536,756 | - |
| 210 | UPB | Upstream Bio, Inc. | 562.70M | 1.08% | 645,990 | 2.85M |
| 211 | TECX | Tectonic Therapeutic, Inc. | 562.36M | -0.03% | 198,720 | - |
| 212 | ALLO | Allogene Therapeutics, Inc. | 555.81M | -25.49% | 42,304,967 | 22.00K |
| 213 | LYEL | Lyell Immunopharma, Inc. | 545.18M | -5.77% | 130,853 | 36.00K |
| 214 | ACRS | Aclaris Therapeutics, Inc. | 544.86M | 0.51% | 2,684,257 | 7.83M |
| 215 | ZURA | Zura Bio Limited | 542.72M | 0.70% | 657,635 | - |
| 216 | VALN | Valneva SE | 542.07M | -0.65% | 91,455 | 205.07M |
| 217 | VSTM | Verastem, Inc. | 539.31M | 8.48% | 3,515,752 | 30.91M |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 526.14M | 2.20% | 1,036,048 | 80.00M |
| 219 | IMMX | Immix Biopharma, Inc. | 522.17M | 1.65% | 519,894 | - |
| 220 | STTK | Shattuck Labs, Inc. | 512.44M | 0.15% | 330,522 | 1.00M |
| 221 | AGMB | AgomAb Therapeutics NV | 510.27M | 0.48% | 229,906 | - |
| 222 | ENGN | enGene Therapeutics Inc. | 509.12M | 2.29% | 140,825 | - |
| 223 | LRMR | Larimar Therapeutics, Inc. | 505.91M | 0.21% | 1,114,199 | - |
| 224 | TRDA | Entrada Therapeutics, Inc. | 505.08M | 1.01% | 89,461 | 25.42M |
| 225 | LXEO | Lexeo Therapeutics, Inc. | 494.16M | 4.55% | 880,039 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 493.16M | -3.78% | 1,052,341 | 85.21M |
| 227 | ADCT | ADC Therapeutics SA | 490.39M | 1.31% | 542,053 | 81.36M |
| 228 | CTNM | Contineum Therapeutics, Inc. | 484.25M | 1.65% | 186,828 | - |
| 229 | ABSI | Absci Corporation | 482.02M | 3.28% | 3,220,557 | 2.80M |
| 230 | RGNX | REGENXBIO Inc. | 480.04M | 2.88% | 577,710 | 170.44M |
| 231 | STRO | Sutro Biopharma, Inc. | 476.81M | 9.89% | 509,710 | 102.48M |
| 232 | VTVT | vTv Therapeutics Inc. | 475.66M | 3.32% | 18,409 | 17.00K |
| 233 | ARMP | Armata Pharmaceuticals, Inc. | 471.83M | 10.18% | 41,733 | 4.90M |
| 234 | XOMA | XOMA Royalty Corporation | 469.60M | 1.82% | 138,168 | 52.15M |
| 235 | ASMB | Assembly Biosciences, Inc. | 467.00M | 0.68% | 81,143 | 72.30M |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 462.10M | 1.58% | 238,430 | - |
| 237 | IVVD | Invivyd, Inc. | 455.31M | -6.40% | 2,501,402 | 53.43M |
| 238 | AURA | Aura Biosciences, Inc. | 454.83M | 2.60% | 301,400 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 453.88M | 10.42% | 136,184 | - |
| 240 | DNA | Ginkgo Bioworks Holdings, Inc. | 449.36M | 15.57% | 2,016,576 | 170.16M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.41M | 0.56% | 132,158 | - |
| 242 | PRTC | PureTech Health plc | 434.01M | 0.34% | 7,330 | 6.39M |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 432.67M | 2.23% | 1,123,137 | 216.11M |
| 244 | ALT | Altimmune, Inc. | 428.05M | 1.86% | 1,990,993 | 41.00K |
| 245 | IPSC | Century Therapeutics, Inc. | 425.94M | 4.41% | 1,857,664 | 109.16M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 424.55M | 2.52% | 111,170 | 66.98M |
| 247 | CLYM | Climb Bio, Inc. | 422.75M | 2.55% | 433,781 | - |
| 248 | YDES | YD Bio Limited | 400.82M | -2.44% | 40,695 | 510.36K |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 397.21M | - | 2,430,530 | - |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 5.30% | 763,763 | 14.56M |
| 251 | IRD | Opus Genetics, Inc. | 394.88M | -0.36% | 397,922 | 14.20M |
| 252 | AUTL | Autolus Therapeutics plc | 393.89M | 0.68% | 1,522,900 | 75.39M |
| 253 | OVID | Ovid Therapeutics Inc. | 390.35M | 6.09% | 4,970,151 | 7.25M |
| 254 | MNPR | Monopar Therapeutics Inc. | 387.61M | 3.28% | 238,621 | - |
| 255 | NAUT | Nautilus Biotechnology, Inc. | 387.29M | 3.03% | 295,235 | - |
| 256 | PBYI | Puma Biotechnology, Inc. | 385.14M | - | 297,770 | 228.37M |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 381.86M | 1.69% | 227,101 | 35.11M |
| 258 | NAGE | Niagen Bioscience, Inc. | 376.36M | 1.74% | 595,973 | 129.42M |
| 259 | CADL | Candel Therapeutics, Inc. | 373.56M | 4.72% | 1,203,426 | - |
| 260 | NMRA | Neumora Therapeutics, Inc. | 369.54M | -1.46% | 2,097,451 | - |
| 261 | ZNTL | Zentalis Pharmaceuticals, Inc. | 368.84M | -6.47% | 2,361,697 | 26.87M |
| 262 | RZLT | Rezolute, Inc. | 368.75M | -1.66% | 874,117 | - |
| 263 | SRZN | Surrozen, Inc. | 365.85M | 6.66% | 287,305 | 3.48M |
| 264 | PRLD | Prelude Therapeutics Incorporated | 363.15M | 0.69% | 204,662 | 12.14M |
| 265 | CABA | Cabaletta Bio, Inc. | 362.91M | 1.87% | 1,442,056 | - |
| 266 | GLSI | Greenwich LifeSciences, Inc. | 360.50M | -5.35% | 125,258 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 352.72M | 1.61% | 600,394 | 72.59M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 352.39M | 3.81% | 142,377 | - |
| 269 | IMRX | Immuneering Corporation | 349.77M | -5.09% | 997,626 | - |
| 270 | PALI | Palisade Bio, Inc. | 344.89M | 3.52% | 4,086,143 | - |
| 271 | NGEN | NervGen Pharma Corp. | 339.10M | 2.44% | 157,843 | - |
| 272 | EDIT | Editas Medicine, Inc. | 331.79M | 5.94% | 2,318,160 | 40.52M |
| 273 | NGNE | Neurogene Inc. | 323.32M | 7.68% | 107,624 | 925.00K |
| 274 | AVTX | Avalo Therapeutics, Inc. | 316.76M | 4.20% | 544,554 | 59.00K |
| 275 | ACIU | AC Immune SA | 316.45M | -3.33% | 176,832 | 4.51M |
| 276 | CLLS | Cellectis S.A. | 310.92M | -2.80% | 29,982 | 79.59M |
| 277 | LENZ | LENZ Therapeutics, Inc. | 310.41M | 2.80% | 790,305 | 19.09M |
| 278 | PLYX | Polaryx Therapeutics, Inc. | 306.31M | 4.86% | 141,926 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 296.08M | 2.57% | 1,146,618 | 5.82M |
| 280 | NBP | NovaBridge Biosciences | 293.75M | 5.83% | 1,040,548 | - |
| 281 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | -0.58% | 1,377,061 | 1.00 |
| 282 | AVXL | Anavex Life Sciences Corp. | 289.14M | 0.32% | 1,789,066 | - |
| 283 | SLN | Silence Therapeutics plc | 289.07M | 1.83% | 652,336 | 559.00K |
| 284 | FHTX | Foghorn Therapeutics Inc. | 284.70M | 3.41% | 99,471 | 30.91M |
| 285 | TARA | Protara Therapeutics, Inc. | 277.45M | 1.18% | 660,095 | - |
| 286 | HELP | Cybin Inc. | 273.20M | 0.55% | 799,951 | - |
| 287 | CGEN | Compugen Ltd. | 272.32M | 4.35% | 885,119 | 72.76M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 271.26M | -1.03% | 620,631 | 114.70K |
| 289 | CHRS | Coherus Oncology, Inc. | 269.80M | 5.26% | 1,031,680 | 42.17M |
| 290 | CCCC | C4 Therapeutics, Inc. | 269.32M | - | 3,934,289 | 35.95M |
| 291 | ALEC | Alector, Inc. | 265.97M | 3.43% | 393,996 | 21.05M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 263.93M | 4.88% | 168,054 | 33.48M |
| 293 | NERV | Minerva Neurosciences, Inc. | 254.02M | 2.98% | 138,346 | - |
| 294 | ADAG | Adagene Inc. | 251.74M | -0.78% | 251,714 | 7.67M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 250.08M | 3.57% | 32,541 | 19.39M |
| 296 | MIST | Milestone Pharmaceuticals Inc. | 248.98M | 1.50% | 2,323,856 | 1.55M |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 246.71M | 2.60% | 339,703 | 82.03M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 243.09M | -0.62% | 906,851 | - |
| 299 | VYGR | Voyager Therapeutics, Inc. | 234.82M | 2.60% | 559,474 | 40.37M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 234.68M | -3.02% | 82,429 | 3.50M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 231.27M | 3.19% | 46,473 | - |
| 302 | CNTX | Context Therapeutics Inc. | 230.62M | 2.03% | 1,071,266 | - |
| 303 | KROS | Keros Therapeutics, Inc. | 227.74M | 3.59% | 307,225 | 244.06M |
| 304 | MDWD | MediWound Ltd. | 227.48M | 0.28% | 106,464 | 16.96M |
| 305 | MGNX | MacroGenics, Inc. | 221.82M | 0.58% | 782,363 | 149.50M |
| 306 | ELTX | Elicio Therapeutics, Inc. | 215.79M | 8.21% | 132,902 | - |
| 307 | FENC | Fennec Pharmaceuticals Inc. | 215.47M | 5.40% | 193,732 | 44.64M |
| 308 | CDXS | Codexis, Inc. | 215.36M | 3.04% | 1,343,006 | 70.39M |
| 309 | ALXO | ALX Oncology Holdings Inc. | 212.55M | -7.71% | 661,055 | - |
| 310 | OABI | OmniAb, Inc. | 212.11M | 0.34% | 1,247,934 | 18.67M |
| 311 | PRQR | ProQR Therapeutics N.V. | 209.67M | 10.56% | 457,469 | 19.19M |
| 312 | MENS | Jyong Biotech Ltd. | 205.32M | -4.30% | 183,584 | - |
| 313 | CRBU | Caribou Biosciences, Inc. | 204.87M | 8.72% | 2,679,486 | 11.16M |
| 314 | KRRO | Korro Bio, Inc. | 200.91M | 1.75% | 145,925 | 6.39M |
| 315 | HURA | TuHURA Biosciences, Inc. | 200.27M | 9.76% | 2,734,541 | - |
| 316 | ENLV | Enlivex Ltd. | 193.70M | -2.65% | 734,792 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 193.53M | 6.77% | 384,028 | - |
| 318 | ACHV | Achieve Life Sciences, Inc. | 192.20M | 0.84% | 514,366 | - |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 192.06M | 2.42% | 922,002 | - |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 190.49M | 2.05% | 562,823 | 146.07M |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 190.15M | 3.06% | 735,889 | 52.74M |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 189.64M | 2.85% | 794,030 | 13.11M |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 188.79M | 15.27% | 296,157 | 7.15M |
| 324 | DTIL | Precision BioSciences, Inc. | 186.56M | 1.40% | 260,497 | 34.26M |
| 325 | ARTV | Artiva Biotherapeutics, Inc. | 185.13M | 4.32% | 230,181 | 251.00K |
| 326 | AGEN | Agenus Inc. | 181.24M | 13.73% | 2,670,617 | 114.20M |
| 327 | SGMT | Sagimet Biosciences Inc. | 180.52M | 2.21% | 448,925 | - |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.72M | -1.57% | 273,368 | - |
| 329 | HRTX | Heron Therapeutics, Inc. | 176.68M | 3.35% | 2,705,890 | 154.90M |
| 330 | UNCY | Unicycive Therapeutics, Inc. | 175.15M | 4.83% | 646,113 | - |
| 331 | CNTB | Connect Biopharma Holdings Limited | 172.39M | 7.77% | 524,208 | 64.00K |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 168.33M | 7.08% | 279,898 | 2.80M |
| 333 | TLSA | Tiziana Life Sciences Ltd | 164.63M | 12.61% | 372,174 | - |
| 334 | NKTX | Nkarta, Inc. | 163.26M | - | 540,988 | - |
| 335 | GALT | Galectin Therapeutics Inc. | 162.59M | 5.11% | 121,110 | - |
| 336 | REPL | Replimune Group, Inc. | 161.02M | 14.71% | 21,193,261 | - |
| 337 | SPRO | Spero Therapeutics, Inc. | 160.94M | - | 603,729 | 66.80M |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 160.36M | 3.31% | 2,802,472 | - |
| 339 | FATE | Fate Therapeutics, Inc. | 155.79M | 2.29% | 1,594,675 | 6.65M |
| 340 | IMUX | Immunic, Inc. | 153.95M | -3.28% | 2,877,448 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 153.90M | 0.40% | 178,190 | 2.00M |
| 342 | MOLN | Molecular Partners AG | 153.84M | -1.66% | 4,632 | 856.30K |
| 343 | HUMA | Humacyte, Inc. | 153.44M | 3.13% | 4,121,173 | 2.04M |
| 344 | BDTX | Black Diamond Therapeutics, Inc. | 152.39M | -2.21% | 1,157,342 | 70.00M |
| 345 | IPHA | Innate Pharma S.A. | 150.51M | 13.19% | 65,601 | 10.57M |
| 346 | ACOG | Alpha Cognition Inc. | 141.31M | 8.71% | 39,595 | 10.22M |
| 347 | BMEA | Biomea Fusion, Inc. | 140.98M | 3.72% | 1,546,693 | - |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 133.44M | -7.77% | 140,255 | - |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 128.32M | 1.70% | 34,842 | 39.99K |
| 350 | EQ | Equillium, Inc. | 121.39M | 12.94% | 880,262 | 4.39M |
| 351 | ONCY | Oncolytics Biotech Inc. | 118.45M | -2.86% | 782,537 | - |
| 352 | GNLX | Genelux Corporation | 117.14M | 4.35% | 114,473 | 8.00K |
| 353 | PEPG | PepGen Inc. | 116.80M | - | 1,649,316 | - |
| 354 | CRDF | Cardiff Oncology, Inc. | 111.43M | 2.52% | 901,807 | 593.00K |
| 355 | SEER | Seer, Inc. | 109.46M | 1.04% | 780,478 | 16.58M |
| 356 | CBUS | Cibus, Inc. | 108.17M | -2.07% | 486,429 | 3.64M |
| 357 | KZIA | Kazia Therapeutics Limited | 108.10M | 5.23% | 361,697 | 1.27M |
| 358 | PMN | ProMIS Neurosciences, Inc. | 108.06M | -6.73% | 17,220 | - |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 107.73M | -0.56% | 2,031,986 | - |
| 360 | ANTX | AN2 Therapeutics, Inc. | 107.10M | -1.00% | 561,124 | - |
| 361 | PYXS | Pyxis Oncology, Inc. | 106.81M | -0.58% | 576,590 | 13.86M |
| 362 | SGMO | Sangamo Therapeutics, Inc. | 105.97M | -0.47% | 5,669,626 | 39.55M |
| 363 | COYA | Coya Therapeutics, Inc. | 104.62M | 0.22% | 130,678 | 7.95M |
| 364 | GOSS | Gossamer Bio, Inc. | 101.29M | 7.74% | 6,939,346 | 48.47M |
| 365 | AARD | Aardvark Therapeutics, Inc. | 101.23M | 15.71% | 224,415 | - |
| 366 | TTRX | Turn Therapeutics Inc. | 100.68M | 1.96% | 26,066 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 98.26M | 1.78% | 134,793 | 35.58M |
| 368 | ANIX | Anixa Biosciences, Inc. | 96.56M | 1.05% | 114,035 | - |
| 369 | EXOZ | eXoZymes, Inc. | 93.27M | -4.35% | 7,541 | -700.00 |
| 370 | SPRB | Spruce Biosciences, Inc. | 93.02M | 5.10% | 101,279 | 697.00K |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 90.95M | 1.83% | 2,019,888 | 65.34K |
| 372 | VANI | Vivani Medical, Inc. | 90.57M | 1.90% | 44,576 | - |
| 373 | CGTX | Cognition Therapeutics, Inc. | 87.16M | 0.10% | 896,996 | - |
| 374 | QTTB | Q32 Bio Inc. | 86.02M | 8.69% | 122,276 | 53.74M |
| 375 | LONA | LeonaBio, Inc. | 85.20M | -6.49% | 35,460 | - |
| 376 | PYPD | PolyPid Ltd. | 84.35M | 0.45% | 128,677 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 83.50M | 7.68% | 1,182,300 | 1.63M |
| 378 | MAIA | MAIA Biotechnology, Inc. | 83.12M | 0.74% | 596,898 | - |
| 379 | OKYO | OKYO Pharma Limited | 82.92M | 3.27% | 265,641 | - |
| 380 | NRXP | NRx Pharmaceuticals, Inc. | 82.59M | 9.65% | 1,589,868 | 1.23M |
| 381 | MCRB | Seres Therapeutics, Inc. | 82.54M | 0.35% | 60,658 | 789.00K |
| 382 | ATYR | aTyr Pharma, Inc. | 82.45M | 3.76% | 653,932 | 190.00K |
| 383 | IFRX | InflaRx N.V. | 82.41M | 6.54% | 1,430,938 | 34.44K |
| 384 | GUTS | Fractyl Health, Inc. | 80.70M | 3.82% | 1,685,617 | 3.00K |
| 385 | PLRX | Pliant Therapeutics, Inc. | 80.49M | - | 186,520 | - |
| 386 | NRXS | NeurAxis, Inc. | 80.33M | 2.72% | 145,188 | 3.57M |
| 387 | GANX | Gain Therapeutics, Inc. | 79.84M | 1.07% | 641,450 | - |
| 388 | CSBR | Champions Oncology, Inc. | 79.57M | -0.17% | 3,119 | 57.95M |
| 389 | PMVP | PMV Pharmaceuticals, Inc. | 78.39M | 8.89% | 1,294,087 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 77.93M | - | 248,483 | 63.26M |
| 391 | COEP | Coeptis Therapeutics Holdings, Inc. | 77.42M | 2.81% | 24,202 | 1.36M |
| 392 | PTHS | Pelthos Therapeutics Inc. | 77.18M | - | 11,869 | 16.80M |
| 393 | FLNA | Filana Therapeutics, Inc. | 76.81M | -1.85% | 652,871 | - |
| 394 | IBIO | iBio, Inc. | 75.65M | -0.45% | 458,359 | 300.00K |
| 395 | ACET | Adicet Bio, Inc. | 75.24M | 10.24% | 387,041 | - |
| 396 | XBIT | XBiotech Inc. | 74.09M | 0.83% | 35,857 | - |
| 397 | ESLA | Estrella Immunopharma, Inc. | 72.53M | -2.86% | 35,641 | - |
| 398 | IBO | Impact BioMedical Inc. | 71.41M | -5.33% | 136,938 | 32.00K |
| 399 | BYSI | BeyondSpring Inc. | 71.14M | -1.14% | 15,081 | 1.88M |
| 400 | ICCC | ImmuCell Corporation | 69.93M | 8.72% | 80,831 | 27.64M |
| 401 | ATHE | Alterity Therapeutics Limited | 69.87M | -1.09% | 7,811 | 4.43M |
| 402 | MNOV | MediciNova, Inc. | 69.40M | -2.08% | 58,460 | 409.66K |
| 403 | INKT | MiNK Therapeutics, Inc. | 67.09M | 16.87% | 118,417 | - |
| 404 | GRCE | Grace Therapeutics, Inc. | 66.23M | 12.04% | 747,554 | - |
| 405 | IMA | ImageneBio, Inc. | 64.09M | -5.29% | 585,891 | 800.00K |
| 406 | TCRX | TScan Therapeutics, Inc. | 63.71M | 3.92% | 1,226,229 | 10.33M |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 63.54M | 1.86% | 335,880 | - |
| 408 | OKUR | OnKure Therapeutics, Inc. | 62.97M | 3.48% | 219,435 | - |
| 409 | CING | Cingulate Inc. | 62.21M | -2.73% | 528,081 | - |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 59.79M | -4.79% | 79,187 | - |
| 411 | PDSB | PDS Biotechnology Corporation | 59.16M | -2.75% | 548,710 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 58.61M | 8.26% | 221,454 | 20.70M |
| 413 | OSTX | OS Therapies Incorporated | 58.43M | 5.30% | 639,977 | - |
| 414 | TIL | Instil Bio, Inc. | 57.24M | 0.96% | 13,726 | - |
| 415 | KZR | Kezar Life Sciences, Inc. | 54.25M | -0.94% | 453,488 | - |
| 416 | ALGS | Aligos Therapeutics, Inc. | 54.08M | 1.16% | 77,019 | 2.19M |
| 417 | MGX | Metagenomi Therapeutics, Inc. | 53.80M | 2.14% | 194,014 | 25.21M |
| 418 | RADX | Radiopharm Theranostics Limited | 53.13M | 2.45% | 22,241 | 10.86M |
| 419 | ENTX | Entera Bio Ltd. | 52.68M | 0.89% | 34,113 | 42.00K |
| 420 | MREO | Mereo BioPharma Group plc | 52.51M | 2.81% | 704,747 | 500.00K |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.67M | 1.54% | 26,220 | 43.77M |
| 422 | NTRB | Nutriband Inc. | 49.35M | 2.01% | 4,867 | 2.28M |
| 423 | ACTU | Actuate Therapeutics, Inc. | 49.32M | 14.29% | 613,730 | - |
| 424 | ANVS | Annovis Bio, Inc. | 49.05M | 4.22% | 1,709,407 | - |
| 425 | RNXT | RenovoRx, Inc. | 46.40M | 0.98% | 252,097 | 1.12M |
| 426 | EDSA | Edesa Biotech, Inc. | 46.38M | -11.53% | 420,638 | - |
| 427 | ATOS | Atossa Therapeutics, Inc. | 46.07M | 0.75% | 35,466 | - |
| 428 | RNTX | Rein Therapeutics Inc. | 45.70M | 5.16% | 115,816 | - |
| 429 | NXTC | NextCure, Inc. | 45.47M | 3.65% | 53,113 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | 0.77% | 221,575 | - |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 44.59M | -0.01% | 120,633 | 1.14M |
| 432 | RLYB | Rallybio Corporation | 43.90M | - | 39,608 | 858.00K |
| 433 | CUE | Cue Biopharma, Inc. | 42.78M | -7.26% | 7,376,904 | 27.47M |
| 434 | ATRA | Atara Biotherapeutics, Inc. | 42.12M | 5.32% | 87,524 | 120.77M |
| 435 | LITS | Lite Strategy, Inc. | 41.82M | 0.88% | 326,531 | - |
| 436 | IMMP | Immutep Limited | 41.03M | 2.14% | 583,810 | 5.28M |
| 437 | LSTA | Lisata Therapeutics, Inc. | 40.92M | -9.22% | 323,796 | 170.00K |
| 438 | HYPD | Hyperion DeFi, Inc. | 40.55M | 0.28% | 240,772 | 813.46K |
| 439 | VERU | Veru Inc. | 38.52M | 0.84% | 30,636 | 16.89M |
| 440 | SNSE | Sensei Biotherapeutics, Inc. | 38.47M | -4.81% | 29,768 | - |
| 441 | CELU | Celularity Inc. | 37.49M | 1.56% | 8,988 | 40.58M |
| 442 | CRVO | CervoMed Inc. | 37.41M | 0.75% | 39,297 | 4.01M |
| 443 | PSTV | Plus Therapeutics, Inc. | 37.26M | 0.37% | 575,867 | 5.21M |
| 444 | CVM | CEL-SCI Corporation | 35.29M | 8.46% | 33,495 | - |
| 445 | BOLD | Boundless Bio, Inc. | 34.96M | 30.00% | 6,070,624 | - |
| 446 | PASG | Passage Bio, Inc. | 34.84M | 0.46% | 23,095 | - |
| 447 | EVAX | Evaxion A/S | 34.53M | - | 14,194 | 7.53M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 34.29M | -0.90% | 76,196 | 90.00K |
| 449 | PLUR | Pluri Inc. | 34.17M | 1.77% | 6,687 | 1.34M |
| 450 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.81M | -0.68% | 7,648 | - |
| 451 | ABVC | ABVC BioPharma, Inc. | 33.61M | -1.45% | 139,730 | 797.92K |
| 452 | INMB | INmune Bio Inc. | 33.50M | 1.61% | 258,333 | 50.00K |
| 453 | BCTX | BriaCell Therapeutics Corp. | 33.04M | 3.65% | 146,212 | - |
| 454 | LGVN | Longeveron Inc. | 32.79M | - | 795,835 | 1.20M |
| 455 | APLM | Apollomics, Inc. | 32.64M | 3.19% | 4,664 | 6.93M |
| 456 | TPST | Tempest Therapeutics, Inc. | 32.27M | 5.14% | 314,150 | - |
| 457 | DYAI | Dyadic International, Inc. | 31.70M | 1.25% | 58,607 | 3.09M |
| 458 | PTN | Palatin Technologies, Inc. | 31.42M | 10.70% | 42,318 | 8.96M |
| 459 | KYNB | Kyntra Bio, Inc. | 29.83M | 4.10% | 12,394 | 6.44M |
| 460 | IGC | IGC Pharma, Inc. | 29.71M | 4.41% | 640,739 | 1.11M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 29.65M | 3.95% | 38,514 | - |
| 462 | SNTI | Senti Biosciences, Inc. | 28.91M | 2.98% | 76,775 | 22.00K |
| 463 | SKYE | Skye Bioscience, Inc. | 27.21M | 12.77% | 363,498 | - |
| 464 | MRKR | Marker Therapeutics, Inc. | 26.51M | -8.62% | 181,581 | 3.55M |
| 465 | OTLK | Outlook Therapeutics, Inc. | 26.47M | -0.55% | 2,648,501 | 205.70K |
| 466 | LTRN | Lantern Pharma Inc. | 26.12M | 4.95% | 287,001 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 26.10M | 1.46% | 548,242 | - |
| 468 | DARE | Daré Bioscience, Inc. | 25.48M | -1.69% | 34,511 | 1.03M |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 25.39M | 3.06% | 22,336 | 14.99M |
| 470 | LEXX | Lexaria Bioscience Corp. | 25.39M | 4.08% | 223,866 | 368.00K |
| 471 | NRSN | NeuroSense Therapeutics Ltd. | 25.10M | 0.93% | 65,046 | - |
| 472 | CRIS | Curis, Inc. | 24.97M | 0.77% | 678,049 | 9.44M |
| 473 | TVGN | Tevogen Bio Holdings Inc. | 24.90M | 7.17% | 25,734 | - |
| 474 | BRNS | Barinthus Biotherapeutics plc | 24.55M | 9.27% | 35,043 | 14.97M |
| 475 | XCUR | Exicure, Inc. | 24.14M | -1.56% | 9,477 | 500.00K |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 23.77M | 4.17% | 975,723 | 789.00K |
| 477 | SER | Serina Therapeutics, Inc. | 23.77M | -1.53% | 169,998 | 130.00K |
| 478 | AEON | AEON Biopharma, Inc. | 22.49M | 3.44% | 72,842 | - |
| 479 | NNVC | NanoViricides, Inc. | 22.46M | - | 56,152 | - |
| 480 | COCP | Cocrystal Pharma, Inc. | 21.09M | 6.99% | 567,215 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.76M | -0.30% | 92,340 | 570.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 19.70M | 4.64% | 190,293 | - |
| 483 | QNTM | Quantum BioPharma Ltd. | 19.62M | -9.99% | 431,129 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 18.82M | - | 163,996 | 320.00K |
| 485 | LPCN | Lipocine Inc. | 18.47M | 6.30% | 567,260 | 1.98M |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 18.44M | 1.10% | 260,442 | 3.94M |
| 487 | PLRZ | Polyrizon Ltd. | 18.35M | -4.88% | 44,021 | - |
| 488 | OSRH | OSR Holdings, Inc. | 17.29M | -3.21% | 471,769 | 2.91M |
| 489 | HIND | Vyome Holdings, Inc. | 16.00M | -1.72% | 33,856 | 319.71K |
| 490 | GNTA | Genenta Science S.p.A. | 15.13M | -0.22% | 40,638 | - |
| 491 | PHIO | Phio Pharmaceuticals Corp. | 14.99M | 4.03% | 240,184 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 14.98M | -10.93% | 137,999 | 1.23M |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 14.28M | -1.38% | 150,792 | 21.80K |
| 494 | INAB | IN8bio, Inc. | 13.69M | 2.96% | 97,551 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.62M | -1.83% | 26,528 | - |
| 496 | CYCN | Cyclerion Therapeutics, Inc. | 13.61M | 11.42% | 328,839 | 2.07M |
| 497 | MBRX | Moleculin Biotech, Inc. | 13.29M | -8.46% | 155,297 | - |
| 498 | BCDA | BioCardia, Inc. | 12.91M | -0.84% | 21,153 | 3.00K |
| 499 | KAPA | Kairos Pharma, Ltd. | 12.84M | 2.48% | 47,270 | - |
| 500 | TRAW | Traws Pharma, Inc. | 12.71M | -1.24% | 35,664 | 2.85M |